Literature DB >> 16819183

Effects of Yukmijihwang-tang derivatives (YMJd) on ibotenic acid-induced amnesia in the rat.

Moonkyu Kang1, Ji-Hyun Kim, Chongwoon Cho, Kwang-Yeun Lee, Minkyu Shin, Moochang Hong, Insop Shim, Hyunsu Bae.   

Abstract

The present study investigates the effects of Yukmijihwang-tang Derivatives (YMJd) on learning and memory through the Morris water maze task and the central cholinergic system of rats with excitotoxic medial septum (MS) lesion. In the water maze test, the animals were trained to find a platform in a fixed position for 6 d and then received a 60-s probe trial in which the platform was removed from the pool on the 7th day. Ibotenic lesion of the MS showed the impaired performance in the Morris water maze test and severe cell losses in the MS, as indicated by decreased choline acetyltransferase-immunoreactivity in the medial septum. Daily administrations of YMJd (100 mg/kg, i.p.) for 21 consecutive days produced significant reversals of ibotenic acid-induced deficit in learning and memory. These treatments also reduced the loss of choline acetyltransferase (ChAT) immunoreactivity in the MS induced by ibotenic acid. These results suggest that impairments of spatial learning and memory might be attributable to the degeneration of septohippocampal cholinergic (SHC) neurons and that YMJd treatment ameliorated learning and memory deficits partly due through neuroprotective effects on the central acetylcholine system. Our studies suggest that YMJd might be useful in the treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819183     DOI: 10.1248/bpb.29.1431

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.

Authors:  Minsook Ye; Hwan-Suck Chung; Yong Ho An; Su-Jin Lim; Won Choi; A Ram Yu; Jin Su Kim; Manho Kang; Seunghun Cho; Insop Shim; Hyunsu Bae
Journal:  Mol Neurobiol       Date:  2015-10-07       Impact factor: 5.590

2.  Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.

Authors:  In Sik Shin; Mee Young Lee; Hye Kyung Ha; Chang Seob Seo; Hyeun-Kyoo Shin
Journal:  BMC Complement Altern Med       Date:  2012-04-20       Impact factor: 3.659

3.  Safety and efficacy assessment of standardized herbal formula PM012.

Authors:  Sung-Hwa Sohn; Soo-Jeong Kim; Yong Kim; Insop Shim; Hyunsu Bae
Journal:  BMC Complement Altern Med       Date:  2012-03-29       Impact factor: 3.659

4.  Yukmijihwang-tang for the treatment of xerostomia in the elderly: study protocol for a randomized, double-blind, placebo-controlled, two-center trial.

Authors:  Gajin Han; Jae-Woo Park; Seok-Jae Ko; Jihee Son; Jongki Seon; Juyeon Kim; Seulki Kim; Inkwon Yeo; Bongha Ryu; Jinsung Kim
Journal:  Trials       Date:  2013-09-03       Impact factor: 2.279

5.  Subacute Oral Toxicity of Yukmijiwhang-Tang in Crl:CD Sprague-Dawley Rats and Its Cytotoxicity.

Authors:  Soo-Jin Jeong; Chang-Seob Seo; Jung-Im Huh; Hyeun-Kyoo Shin
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-05       Impact factor: 2.629

6.  An Aqueous Extract of Herbal Medicine ALWPs Enhances Cognitive Performance and Inhibits LPS-Induced Neuroinflammation via FAK/NF-κB Signaling Pathways.

Authors:  Ju-Young Lee; Bitna Joo; Jin Han Nam; Hye Yeon Nam; Wonil Lee; Youngpyo Nam; Yongtaek Seo; Hye-Jin Kang; Hyun-Ji Cho; Young Pyo Jang; Jeongyeon Kim; Young-Man We; Ja Wook Koo; Hyang-Sook Hoe
Journal:  Front Aging Neurosci       Date:  2018-09-26       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.